1. Home
  2. CBLL

as of 08-10-2026 3:51pm EST

$19.24
$0.06
-0.31%
Stocks Nasdaq

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Founded: 2014 Country:
United States
United States
Employees: N/A City: SUNNYVALE
Market Cap: 726.2M IPO Year: 2024
Target Price: $23.20 AVG Volume (30 days): 318.6K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.03 EPS Growth: 56.93
52 Week Low/High: $10.85 - $24.33 Next Earning Date: 05-11-2026
Revenue: $89,063,000 Revenue Growth: 36.09%
Revenue Growth (this year): 29.57% Revenue Growth (next year): 28.44%
P/E Ratio: N/A Index: N/A
Free Cash Flow: -41575000.0 FCF Growth: N/A

Share on Social Networks: